Performance of risk assessment models for venous thromboembolism in critically ill patients receiving pharmacologic thromboprophylaxis: a post hoc analysis of the PREVENT trial

RECOMMENDED

Lung Cancer

CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Lung Cancer

Suazo-Zepeda E, Viddeleer AR, Maas WJ, Postmus D, Heuvelmans MA, Hiltermann TJN, De Bock GH

doi: 10.1016/j.lungcan.2024.108054

RECOMMENDED

Asthma

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

★ 3 Recommended by Dr Martin Frey, Faculty Member

Lancet Respir Med

Meulmeester FL, Mailhot-Larouche S, Celis-Preciado C, Lemaire-Paquette S, Ramakrishnan S, Wechsler ME, Brusselle G, Corren J, Hardy J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Santoro E, Compton C, Hardin ME, Holweg CTJ, Subhashini A, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Couillard S

doi: 10.1016/S2213-2600(25)00037-2

RECOMMENDED

COPD

Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Respir Res

Xu Z, Li F, Xin Y, Wang Y, Wang Y

doi: 10.1186/s12931-024-03033-4

RECOMMENDED

Further Publications

Rethinking Blood Eosinophils for Assessing ICS Response in COPD: A Post-Hoc Analysis from FLAME

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Mathioudakis AG, Bate S, Sivapalan P, Stæhr Jensen JU, Singh D, Vestbo J

doi: 10.1016/j.chest.2024.06.3790

Tuberculosis

Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial

Lancet Infect Dis

Ismail N, Moultrie H, Mwansa-Kambafwile J, Copas A, Izu A, Moyo S, Skinner D, Ismail F, Gosce L, Omar SV, Abubakar I, Madhi SA

doi: 10.1016/S1473-3099(24)00816-8

Interstitial Lung Disease

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

Semin Arthritis Rheum

Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA

doi: 10.1016/j.semarthrit.2024.152561

RECOMMENDED

Asthma

Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Eriksson S, Giezeman M, Hasselgren M, Janson C, Kisiel MA, Montgomery S, Nager A, Sandelowsky H, Ställberg B, Sundh J, Lisspers K

doi: 10.2147/JAA.S460051

COPDLung Cancer

Construction and Validation of a Nomogram Prediction Model for Death Risk in Patients with Chronic Obstructive Pulmonary Disease Complicated by Hypercapnic Respiratory Failure in the Intensive Care Unit

Respir Med

Zhang Y, Chen H, Hu S, Chen C, Chen W

doi: 10.1016/j.rmed.2025.108188

RECOMMENDED

Further Publications

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history

★ 2 Recommended by Dr Martin Frey, Faculty Member

Respir Res

Muro S, Kawayama T, Sugiura H, Seki M, Duncan EA, Bowen K, Marshall J, Megally A, Patel M

doi: 10.1186/s12931-024-02918-8

Related content

CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis

Rethinking Blood Eosinophils for Assessing ICS Response in COPD: A Post-Hoc Analysis from FLAME

Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study

Construction and Validation of a Nomogram Prediction Model for Death Risk in Patients with Chronic Obstructive Pulmonary Disease Complicated by Hypercapnic Respiratory Failure in the Intensive Care Unit

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history